Breast cancer is on the rise: data reveal drastic gap in survival rates
Summary: Despite fewer breast cancer cases, low- and middle-income countries have higher death rates due to limited screening and treatment options compared to wealthy nations.Pfizer appoints new CMO
Summary:
Pfizer names Patrizia Cavazzoni, former FDA drug review office head, as chief medical officer, replacing Aida Habtezion. Her appointment may raise regulatory “revolving door” concerns.
Takeda invests in novel small-molecule development
Summary:
Takeda invests $770M in BridGene to target “undruggable” molecules, using the IMTAC platform to develop novel small-molecule drugs for immunology and neurology targets.
NIH Funding Cuts Threaten Biotech Innovation Pipeline
Summary:
Trump’s NIH funding cuts, especially limiting indirect costs to 15%, threaten biotech innovation by reducing basic research that fuels new drug development and startups.
Biggest-ever AI biology model writes DNA on demand
Summary:
Scientists released Evo 2, the largest-ever AI biology model, trained on 128,000 genomes. It can write chromosomes and interpret complex non-coding DNA.
